Sun Pharma to launch its first innovative product for psoriasis in Japan

     Sun Pharma to launch its first innovative 
              product for psoriasis in Japan





Sun Pharmaceutical Industries got approval for its psoriasis drug Ilumya, a part of its specialty products portfolio, for the Japan market. This would strengthen Sun Pharma's dermatology portfolio in Japan, but analysts caution that the segment has been witnessing price erosion of late.
It is the first innovative drug that Sun would launch in Japan. The approval was expected earlier by analysts.
Sun Pharma's stock reacted positively to the news, ending the day at Rs 481.8 on BSE, up marginally.

Read more...